ClinicalTrials.Veeva

Menu

Effect of Intermittent Versus Continuous Subglottic Secretion Drainage on Tracheal Mucosa Damages (ASPIRE)

R

Rennes University Hospital

Status and phase

Terminated
Phase 3

Conditions

Mechanical Ventilation Complication

Treatments

Device: Intermittent subglottic secretion drainage
Device: Continuous subglottic secretion drainage

Study type

Interventional

Funder types

Other

Identifiers

NCT01555229
LOC/09-05 (Other Identifier)
2010-A00912-37
CIC0203/124 (Other Identifier)

Details and patient eligibility

About

Endotracheal tubes with subglottic secretion drainage (incorporating a suction port above the cuff) have been shown to reduce the incidence of ventilator-associated pneumonia. Subglottic secretion drainage can be either continuous or intermittent. However, concerns about the safety of continuous subglottic secretion drainage were raised in an experimental study in sheep, which found widespread injuries to tracheal mucosa and/or submucosa. Our objective is therefore to compare intermittent versus continuous subglottic secretion drainage on tracheal mucosa damages in patients requiring mechanical ventilation for an expected duration of more than 24 hours.

Full description

Endotracheal tubes with subglottic secretion drainage (incorporating a suction port above the cuff) have been shown to reduce the incidence of ventilator-associated pneumonia. Subglottic secretion drainage can be either continuous or intermittent. However, concerns about the safety of continuous subglottic secretion drainage were raised in an experimental study in sheep, which found widespread injuries to tracheal mucosa and/or submucosa. Our objective is therefore to compare intermittent versus continuous subglottic secretion drainage on tracheal mucosa damages in patients requiring mechanical ventilation for an expected duration of more than 24 hours. Tracheal mucosa injuries will be assessed by tracheal fibroscopy. Secondary endpoints are the volume of daily secretions suctioned, the occurrence of difficulties or impossibilities of secretion drainage, and the occurrence of ventilator-associated pneumonia.

Enrollment

80 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult aged 18 years or more
  • Patients hospitalized in intensive care unit
  • Patients requiring endotracheal tube with an expected mechanical ventilation duration of more than 24 hours

Exclusion criteria

  • Pregnant or breast-feeding women
  • Previous known tracheal lesions
  • Persons deprived of freedom

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

80 participants in 2 patient groups

Intermittent drainage
Experimental group
Description:
Intermittent subglottic secretion drainage at -100 mmHg during 8 sec every 15 seconds.
Treatment:
Device: Intermittent subglottic secretion drainage
Continuous drainage.
Active Comparator group
Description:
Continuous subglottic secretion drainage at -20 mmHg.
Treatment:
Device: Continuous subglottic secretion drainage

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems